文献速递肾小球疾病

印度膜性肾病患者特征分析

Profile of Indian Patients With Membranous Nephropathy.
PubMed 文献 · Kidney Int Rep · 2020-07-02

该研究回顾性分析2014-2017年印度单中心216例膜性肾病(MN)活检及血清样本,采用PLA2R免疫荧光、THSD7A免疫组化及抗PLA2R ELISA检测。结果显示原发性MN中PLA2R相关占72.8%,THSD7A相关占3.4%,儿童PLA2R阳性率44%。

要点

  • 印度原发MN中PLA2R相关占72.8%,与全球数据相似。
  • THSD7A在原发MN中占3.4%,儿童中PLA2R阳性率44%。
  • PLA2R在继发MN中检出16.7%,以狼疮性MN最常见。

核心结论

  • 印度MN患者中PLA2R和THSD7A相关MN的患病率与全球文献相似,包括儿童队列。

研究设计与样本

  • 回顾性分析2014-2017年印度单中心所有MN病例,对活检组织行PLA2R直接免疫荧光和THSD7A免疫组化,对基线血清行抗PLA2R ELISA。

主要发现

  • MN占研究期间肾活检的10%。
  • 216例有足够组织行PLA2R免疫荧光,其中110例有血清行PLA2R ELISA。
  • 结合两种方法,PLA2R相关原发性MN患病率为72.8%,两种方法中度一致(kappa 0.61)。
  • 继发性MN中PLA2R检出率为16.7%,最常见于狼疮性MN。
  • 176例THSD7A免疫组化显示原发性MN中患病率3.4%,1例狼疮性MN also阳性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The majority of primary membranous nephropathy (MN) cases are no longer considered idiopathic with the discovery of the podocytic autoantigens: phospholipase A2 receptor (PLA2R) and thrombospondin type 1 domain-containing 7A (THSD7A). Limited data on PLA2R-related MN in Indians exist in literature, and THSD7A-related MN remains undocumented in this population. We aimed to characterize the baseline PLA2R and THSD7A profile of adult and pediatric membranous nephropathy (MN) in a large Indian single-institution cohort. METHODS: A retrospective analysis of all cases of MN (primary and secondary) between 2014 and 2017 was performed with PLA2R direct immunofluorescence and THSD7A immunohistochemistry on the biopsies and anti-PLA2R enzyme-linked immunosorbent assay (ELISA) on baseline sera. RESULTS: MN constituted 10% of kidney biopsies received in the study period. A total of 216 cases with adequate tissue underwent PLA2R direct immunofluorescence, and 110 of them had available sera for PLA2R ELISA. Combining both testing methods, the prevalence of PLA2R-related primary MN was 72.8%, with moderate concordance between the 2 methods (kappa 0.61). PLA2R was also detected in 16.7% cases of secondary MN, most commonly lupus MN. THSD7A immunohistochemistry performed on 176 cases showed a prevalence of 3.4% in primary MN. One case of lupus MN was also positive for THSD7A. Dual positivity (PLA2R and THSD7A) was noted in 2 cases. The large pediatric cohort tested showed a prevalence of 44% of PLA2R based on tissue testing, whereas 1 case demonstrated THSD7A positivity. CONCLUSION: This study in a large cohort of Indian patients demonstrates prevalence rates of PLA2R- and THSD7A-related MN similar to world literature, including the substantial cohort of pediatric MN. It also confirms variation in MN in the form of outliers within PLA2R (related to tissue and serum testing), dual positivity for PLA2R and THSD7A, and PLA2R/THSD7A-positive secondary MN.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Subramanian P, Kumar H, Tiwari B, et al. Profile of Indian Patients With Membranous Nephropathy. Kidney Int Rep. 2020. PMID: 32954080. doi:10.1016/j.ekir.2020.06.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。